HPV prevalence

Biomarker1 paper1 finding

Humans1

Upstream

1

Temporal trends

downin humans1

1 study

temporal trends decrease HPV prevalence in humans.
Humansfemalesn = 3,751
Temporal trends in cervical cancer screening participation, barriers, HPV infection, and cytopathological profiles before, during, and after the COVID-19 pandemic in Cameroon · Research Square · 15 Sep 2026 · Preprint

Latest

9

Frontiers in Public HealthHumansYesterday

Prevalence and genotype distribution of human papillomavirus infection among women undergoing HPV testing at a hospital in Zhangzhou, China: a retrospective study

Human papillomavirus infection

medRxivIn silicoPreprint2 Oct

Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria

medRxivHumansPreprint30 Sep

Impact of HPV vaccination on high-risk HPV prevalence in 25-29-year-old women attending cervical screening in England 2016-2025

BMC Public HealthHumans26 Sep

Geographic and temporal variations in cancer incidence attributable to human papillomavirus infection in China: a population-based study

IntervirologyHumans23 Sep

HUMAN PAPILLOMAVIRUS GENOTYPE DISTRIBUTION AMONG ADULT WOMEN IN THE RABAT REGION (MOROCCO): A RETROSPECTIVE AND ANALYTICAL STUDY WITH IMPLICATIONS FOR HPV VACCINATION STRATEGIES

BMC ProceedingsReview22 Sep

Elimination of HPV-associated cancers: universal HPV vaccination and the role of anal screening - a meeting report

Industry & policy

Research SquareHumansPreprint16 Sep

Temporal trends in cervical cancer screening participation, barriers, HPV infection, and cytopathological profiles before, during, and after the COVID-19 pandemic in Cameroon

Human papillomavirus infection

AJOG Global ReportsHumans29 Aug

Integrating a "see-and-treat" approach with opportunistic human papilloma virus deoxyribonucleic acid (HPV DNA) based cervical cancer screening in India: a retrospective cross-sectional study

Cervical cancer

MicroorganismsHumans27 Aug

Epidemiological Profile of High-Risk HPV in Cervical Samples for Liquid-Based Cytology: Insights from Screening and Symptomatic Cohorts